A read of the print editions of Wednesday's Wall St. Journal, Financial Times, Investor's Business Daily, New York Times, USA Today, Atlanta Journal Constitution & Daily Report (Ga. - carries Bloomberg) yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by a separate table of Dow component's symbol and Tuesday's stock prices and related data in alphabetical order.
Dow Jones Average: The Dow Jones Industrial Average closed Tuesday at 13,551.78 up 127.55 or 0.95 % from Monday's close of 13,424.23. For the year the Dow is up 10.92%. Of the Dow components 24 gained, GE was unchanged and 5 declined. The biggest gainer dollar-wise was Caterpillar up $2.19 and percentage-wise was Intel up 2.85%. The biggest decliner dollar-wise and percentage-wise was UnitedHealth down 60 cents or 1.04%.
WSJ pC1 "Turnaround in sentiment sparks rally for blue chips" by Jonathan Cheng et al says in 2 days the Dow rebounded from its beating last week with its biggest gain since 9/13 the day the Fed said it wold stimulate the economy. The turnaround was due to the mood turning more positive about European leaders helping Spain. Also Moody's affirmed Spain's credit ratings. After the close tech firms IBM and Intel both reported disappointing earnings. IBM then dropped 3.4% which will shave 60 points off the Dow if the decline continues. Johnson & Johnson rose 95 cents after its 3Q earnings & rev edged above expectations, while its full year earnings outlook was in line with forecasts. But UnitedHealth dropped 61 cents making it the Dow's biggest decliner after it voiced caution about '13 earnings. Coke fell 23 cents after its 3Q earnings matched estimates amid signs of slowing growth.
NYT pB12 "Strong earnings reports at bellwetehr companies bolster shares" by Reuters says stocks rallied Tues giving the S&P its best 2 day advance in a month as strong earnings from Johnson & Johnson & other bellwether firms raised hopes for the rest of the quartely reporting season. After the bell IBM shares fell3% after the release of its results.
IBD pB6 "Stocks rebound further as Nasdaq regains its 50 day" by Victor Reklaitis says stocks achieved solid gains for a 2nd straight day Tues as they cotninued to recover from last week's sell off. Action was broad advance in higher volume as the current outlook is the market is in correction. Intel was down after Q3 results beat forecats but it gave weak guidance for Q4. IBM fell as its profit matched estimates & sales missed.
As of the open of the market on Wedneesday the current divisor for the Dow Jones Industrial Average found at page C5 of Wednesday's Wall St. Journal is 0.130216081. Wednesday's trailing P/E ratio is 14.71 up from yesterday's trailing P/E ratio of 14.56 (year ago it was 12.72); today's P/E estimate is 12.62 unchanged from Tuesday's P/E estimate of 12.62 (year ago it was 11.70) and today's dividend yield is 2.50 down from yesterday's dividend yield of 2.52 (last year it was 2.67). The Dow's all-time high was 14,164.53 on Oct. 9, 2007. The 12 year low close for the Dow was on March 9, 2009 when it fell to 6,547.05.
Tuesday's Dow Jones Industrial Average closing numerator was 1,764.66 up 16.61 from Monday's closing numerator of 1,748.05. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor. Now, if you divide the Dow numerator increase for today by the divisor (0.130216081) you get the increase in today's Dow. A dollar increase or decrease in a Dow stock results in a $7.68 change in the Dow Index.
The average closing price (the closing numerator divided by 30) of Tuesday's Dow Jones Industrial Average was $58.82 up 55 cent from Monday's closing numerator of $58.27. The median closing price of Tuesday's Dow Jones Industrial Average was $54.09 (DIS/UNH) down 5 cents from Monday's median closing price of $54.14 (DIS/UNH). The lowest volume was 3M and the highest volume again was Bank of America.
If Tuesday morning before the market opened you had purchased 100 shares of each of the Dow Jones Industrial Average 30 shares (assuming you could buy fractional shares and assuming no transaction costs or dividends) and sold at the close you would have made $1,661 ($176,466 - $174,810).
MarketWatch.com Tues. 10/16/12 5:01 pm by Myra P. Saefong & Polya Lesova says U.S. stocks finished higher Tuesday, with the Dow industrials scoring their biggest one-day gain since Sept. 13, buoyed by strong earnings from several major companies and reports that Spain is mulling a request for a line of credit from the European Union.“The market had a solid rally today,” said Robert Fuest, head of investment research at Landor & Fuest Capital Managers. “The continuation will only come if we ... remain on a more positive note — or less negative, if you will — with upcoming economic releases and the continued appearance that the euro zone will continue cooperating with their members.”The blue-chip Dow Jones Industrial Average DJIA+0.95% rallied 127.55 points, or 1%, to close at 13,551.78, with 24 of its 30 components finishing higher.The benchmark index marked a third straight session of gains as well as its highest close since Oct. 8. Its gain was the largest since the day the Federal Reserve announced its third round of quantitative easing.
Several Dow companies reported generally robust earnings ahead of Tuesday’s opening bell, including Johnson & Johnson JNJ+1.38%, UnitedHealth Group Inc. UNH-1.06% and Coca-Cola Co. KO-0.60%.After the market closed Tuesday, though, International Business Machines IBM+0.99% and Intel Corp. INTC+2.85% posted third-quarter financial results, with both reporting a fall in revenue.Spain is considering a request for a line of credit from the European Union's new bailout mechanism, according to a senior Spanish Finance Ministry official.Ahead of the quarterly results, chip maker Intel was the top gainer in the Dow, rallying 2.9%.Health-care conglomerate Johnson & Johnson tacked on 1.4%. The company raised its per-share earnings estimate for the year.The S&P 500 index SPX+1.03% gained 14.79 points, or 1%, to close at 1,454.92, with energy and materials the top gainers among its 10 industry groups. The index also notched its highest close since Oct. 8.Anthony Lazzara, chief executive officer of Newport Beach, Calif.–based Lido Isle Advisors, pointed out that the S&P 500 has reached its key 1,450 level. “Yearly highs are close in sight, and we expect those to be breached soon,” he said.Murphy Oil Corp. MUR+8.03% rallied 8%, the second-best gainer in the S&P 500, on news that the company’s board has approved the spinoff of its U.S. downstream unit.y dividend to 50 cents a share from 46 cents.
Wednesday's Dow News followed by Tuesday's Closing Dow Numbers:
AT&T: WSJ pC14 "No need to run but Sprint ivnestors should prepare for exit" by Miriam Gottfired says Sprint trades at 4.7 times '13 earnings vs 6 times for At&T and 5.4 for Verizon but Sprint has plenty of risks as it needs to finish building its LTE network.
Alcoa: No mentions found.
American Express: No mentions found.
Bank of America: No mentions found.
Boeing: No mentions found.
Caterpillar: No mentions found.
Chevron: No mentions found.
Cisco: No mentions found.
Coke: WSJ pB7 "coke braces for China slump" by Paul Ziobro, NYT pB3 "Strong dollar dents Coke's profit" by Reuters, IBD pA2 "Domino's Q3 hot, Coke's flat say Coke's 3Q earnings rose 3.9% as it sold more drinks globally. Coke's profit was $2.31 bil or 50 cents a share up from $2.22 bil or 48 cents a year earlier. Rev rose 0.8% to $12.34 bil.
WSJ pC1 "Turnaround in sentiment sparks rally for blue chips" by Jonathan Cheng et al says in 2 days the Dow rebounded from its beating last week with its biggest gain since 9/13 the day the Fed said it wold stimulate the economy. The turnaround was due to the mood turning more positive about European leaders helping Spain. Also Moody's affirmed Spain's credit ratings. After the close tech firms IBM and Intel both reported disappointing earnings. IBM then dropped 3.4% which will shave 60 points off the Dow if the decline continues. Johnson & Johnson rose 95 cents after its 3Q earnings & rev edged above expectations, while its full year earnings outlook was in line with forecasts. But UnitedHealth dropped 61 cents making it the Dow's biggest decliner after it voiced caution about '13 earnings. Coke fell 23 cents after its 3Q earnings matched estimates amid signs of slowing growth.
Disney: No mentions found.
DuPont: No mentions found.
Exxon: No mentions found.
GE: No mentions found.
Hewlett-Packard: No mentions found.
Home Depot: No mentions found.
Intel: WSJ pB1 "Intel feeling pain from PC slump" by Don Clark, USAT p1 "Intel, IBM profits take lumps" by Scott Martin, NYT p B2 "In a slow market, Intel exceeds lowered expectations" by Quentin Hardy, IBD pA4 "Intel Q3 beats expectations but Q4 outlook adds doubt" by Patrick Seitz say Intel's 3Q profit dropped 14% due to tough times for PC sector & competition from tablets. Net income was $2.97 bil or 58 cents a share down from profit year ago of $3.47 bil or 65 cents. Rev fell 5.5% to $13.5 bil
WSJ pC1 "Turnaround in sentiment sparks rally for blue chips" by Jonathan Cheng et al says in 2 days the Dow rebounded from its beating last week with its biggest gain since 9/13 the day the Fed said it wold stimulate the economy. The turnaround was due to the mood turning more positive about European leaders helping Spain. Also Moody's affirmed Spain's credit ratings. After the close tech firms IBM and Intel both reported disappointing earnings. IBM then dropped 3.4% which will shave 60 points off the Dow if the decline continues. Johnson & Johnson rose 95 cents after its 3Q earnings & rev edged above expectations, while its full year earnings outlook was in line with forecasts. But UnitedHealth dropped 61 cents making it the Dow's biggest decliner after it voiced caution about '13 earnings. Coke fell 23 cents after its 3Q earnings matched estimates amid signs of slowing growth.
NYT pB12 "Strong earnings reports at bellwetehr companies bolster shares" by Reuters says stocks rallied Tues giving the S&P its best 2 day advance in a month as strong earnings from Johnson & Johnson & other bellwether firms raised hopes for the rest of the quartely reporting season. After the bell IBM shares fell3% after the release of its results.
IBD pB6 "Stocks rebound further as Nasdaq regains its 50 day" by Victor Reklaitis says stocks achieved solid gains for a 2nd straight day Tues as they cotninued to recover from last week's sell off. Action was broad advance in higher volume as the current outlook is the market is in correction. Intel was down after Q3 results beat forecats but it gave weak guidance for Q4. IBM fell as its profit matched estimates & sales missed.
IBM: WSJ pB3 "IBM drop in rev may signal a slowing" by Drew Fitzgerald, USAT p1 "Intel, IBM profits take lumps" by Scott Martin, NYT pB2 "IBM squeezes out a profit as its rev declines" by Steve Lohr, IBD pA4 "IBM reports rare sales miss and shares down after hours" by Brian Deagon say IBM had 3Q profit of $3.82 bil down from $3.84 bil a year ago. Per share earnings rose to $3.33 from $3.19 a year ago. Rev slid 5.4% to $24.75 bil.
WSJ pC1 "Turnaround in sentiment sparks rally for blue chips" by Jonathan Cheng et al says in 2 days the Dow rebounded from its beating last week with its biggest gain since 9/13 the day the Fed said it wold stimulate the economy. The turnaround was due to the mood turning more positive about European leaders helping Spain. Also Moody's affirmed Spain's credit ratings. After the close tech firms IBM and Intel both reported disappointing earnings. IBM then dropped 3.4% which will shave 60 points off the Dow if the decline continues. Johnson & Johnson rose 95 cents after its 3Q earnings & rev edged above expectations, while its full year earnings outlook was in line with forecasts. But UnitedHealth dropped 61 cents making it the Dow's biggest decliner after it voiced caution about '13 earnings. Coke fell 23 cents after its 3Q earnings matched estimates amid signs of slowing growth.
NYT pB12 "Strong earnings reports at bellwetehr companies bolster shares" by Reuters says stocks rallied Tues giving the S&P its best 2 day advance in a month as strong earnings from Johnson & Johnson & other bellwether firms raised hopes for the rest of the quartely reporting season. After the bell IBM shares fell3% after the release of its results.
IBD pB6 "Stocks rebound further as Nasdaq regains its 50 day" by Victor Reklaitis says stocks achieved solid gains for a 2nd straight day Tues as they cotninued to recover from last week's sell off. Action was broad advance in higher volume as the current outlook is the market is in correction. Intel was down after Q3 results beat forecats but it gave weak guidance for Q4. IBM fell as its profit matched estimates & sales missed.
JPMorgan:
Johnson & Johnson: WSJ pB7 "Johnson & Johnson" by Pete Loftus, NYT pB7 "J&J's costs take a toll on its profit" by AP, IBD pA2 "J&J's newer drugs doing well" say Johnson & Johnson's profit fell 7.3% for 3Q on acquisition & research costs, wile the purchase of Synthes fueld a 65% rise in sales as the results topped Wall St expectations & J&J boosted its forecast of full year '12 earnings. 3Q results had J&J earning $2.97 bil or $1.05 per share vs. $3.2 bil or $1.15 a year earlier. 3Q sales rose 6.5% to $17.1 bil.
WSJ pC1 "Turnaround in sentiment sparks rally for blue chips" by Jonathan Cheng et al says in 2 days the Dow rebounded from its beating last week with its biggest gain since 9/13 the day the Fed said it wold stimulate the economy. The turnaround was due to the mood turning more positive about European leaders helping Spain. Also Moody's affirmed Spain's credit ratings. After the close tech firms IBM and Intel both reported disappointing earnings. IBM then dropped 3.4% which will shave 60 points off the Dow if the decline continues. Johnson & Johnson rose 95 cents after its 3Q earnings & rev edged above expectations, while its full year earnings outlook was in line with forecasts. But UnitedHealth dropped 61 cents making it the Dow's biggest decliner after it voiced caution about '13 earnings. Coke fell 23 cents after its 3Q earnings matched estimates amid signs of slowing growth.
USAT p6B Charts Johnson & Johnson & Microsoft.
McDonald's: No mentions found.
Merck: No mentions found.
Microsoft: WSJ pB4 "Microsoft Tablet: $499" by Shira Ovide & WSJ pD1 "Windows pushes into the Tablet age" by Walter S. Mossberg, USAT p3B "What changes can you expect in Windows 8?" by Edward C. Baig review the new style apps and touch interface that modernize the old school op system for Windows.
USAT p6B Charts Johnson & Johnson & Microsoft.
Pfizer: No mentions found.
Procter & Gamble: No mentions found.
3M: No mentions found.
Travelers: No mentions found.
UnitedHealth: WSJ pB7 "UnitedHealth" by Jon Kemp, IBD pA1 "UnitedHealth Q3 sales short" say its 3Q earnings rose 23% as it boosted its membership, kept a lid on medical costs and saw improvement in iths health services biz. It had a profit of $1.56 bil or $1.50 per share up from $1.27 bil or $1.17 a share a year earlier. Rev jumped 8% to $27.3 bil, shy of the $27.61 bil expected.
WSJ pC1 "Turnaround in sentiment sparks rally for blue chips" by Jonathan Cheng et al says in 2 days the Dow rebounded from its beating last week with its biggest gain since 9/13 the day the Fed said it wold stimulate the economy. The turnaround was due to the mood turning more positive about European leaders helping Spain. Also Moody's affirmed Spain's credit ratings. After the close tech firms IBM and Intel both reported disappointing earnings. IBM then dropped 3.4% which will shave 60 points off the Dow if the decline continues. Johnson & Johnson rose 95 cents after its 3Q earnings & rev edged above expectations, while its full year earnings outlook was in line with forecasts. But UnitedHealth dropped 61 cents making it the Dow's biggest decliner after it voiced caution about '13 earnings. Coke fell 23 cents after its 3Q earnings matched estimates amid signs of slowing growth.
United Technologies: No mentions found.
Verizon: WSJ pC14 "No need to run but Sprint ivnestors should prepare for exit" by Miriam Gottfired says Sprint trades at 4.7 times '13 earnings vs 6 times for At&T and 5.4 for Verizon but Sprint has plenty of risks as it needs to finish building its LTE network.
Walmart: No mentions found.
Tuesday's Closing Dow Numbers:
| Symbol | Last Sale | Change | % Change | Share Volume | Market |
| T |  | NYSE | |||
| AA | | NYSE | |||
| AXP | | NYSE | |||
| BAC | | NYSE | |||
| BA | | NYSE | |||
| CAT | | NYSE | |||
| CVX | | NYSE | |||
| CSCO | | NASDAQ-GS | |||
| KO |  | NYSE | |||
| DIS | | NYSE | |||
| DD | | NYSE | |||
| XOM | | NYSE | |||
| GE |  | NYSE | |||
| HPQ | | NYSE | |||
| HD | | NYSE | |||
| INTC | | NASDAQ-GS | |||
| IBM | | NYSE | |||
| JPM | | NYSE | |||
| JNJ | | NYSE | |||
| MCD | | NYSE | |||
| MRK | | NYSE | |||
| MSFT | | NASDAQ-GS | |||
| PFE | | NYSE | |||
| PG | | NYSE |
| MMM | | NYSE | |||
| TRV | | NYSE | |||
| UNH | | NYSE | |||
| UTX | | NYSE | |||
| VXZ | | PSE | |||
| WMT | | NYSE |
*********************
Here are the current CEOs of the Dow 30 Companies:
AT&T T Randall L. Stephenson (Dallas, TX)
Alcoa AA Klaus Kleinfeld (NY, NY)
American Express AXP Kenneth I. Chenault (NY, NY)
Bank of America BAC Brian T. Moynihan (Charlotte, N.C.)
Boeing BA W. James McNerney, Jr. (Chicago, Ill)
Caterpillar CAT Douglas Oberhelman (Peoria, Ill.)
Chevron CVX John Watson (San Ramon, CA)
Cisco CSCO John Chambers (San Jose, CA)
Coca Cola KO Muhtar Kent (Atlanta, GA)
Disney DIS Robert Iger (Burbank, CA)
DuPont DD Ellen Kullman (Wilmington, DE)
ExxonMobil XOM Rex W. Tillerson (Irving, Tx)
GE Jeffrey R. Immelt (Fairfield, CT)
Hewlett-Packard HPQ Meg Whitman (Palo Alto, CA)
Home Depot HD Frank Blake (Atlanta, GA)
Intel INTC Paul S. Otellini (Santa Clara, CA)
IBM Virginia M. Rometty (Armonk, NY)
JPMorgan Chase JPM Jamie Dimon (NY, NY)
Johnson & Johnson JNJ Alex Gorsky (New Brunswick, NJ)
McDonald's MCD Donald Thompson (Oak Brook, Ill)
Merck MRK Kenneth Frazer (Whitehouse Station, N.J.)
Microsoft MSFT Steve Ballmer (Redmond, WA)
Pfizer PFE Ian Read (NY, NY)
Procter & Gamble PG Bob McDonald (Cincinnati, OH)
3M MMM Inge Thulin (St. Paul, MN)
Travelers TRV Jay S. Fishman (NY, NY)
UnitedHealthUNC Stephen Hemsley (Minnetonka, MN)
United Technologies UTX Louis Chenevert (Hartford, CT)
Verizon VZ Lowell McAdam (NY, NY)
Wal-Mart WMT Mike Duke (Bentonville, ARK)
***************************
Here are the Dow Jones Industrial Average 30 as of 10,4/12 ranked in order of market capitalization rounded to the nearest 1/2 billion followed by number of shares outstanding rounded to the nearest 1/2 billion:
1. Exxon Mobil XOM $426.5 [4.5]
2. Microsoft MSFT 252 [8.5]
3.WalMart WMT 251 [3.5]
4. GE 242.5 [10.5]
5. IBM 240.5 [1]6. Chevron CVX 230 [2]
7. AT&T T 221 [6]
8. Procter & Gamble PG 191.5 [3]
9. Johnson & Johnson JNJ 191 [3]
10. Pfizer PFE 189.5 [7.5]
11. Coke KO 172.5 [4.5]
12. JPMorgan Chase JPM 159 [4]
13. Merck MRK 140.5 [3]
14. Verizon VZ 134.5 [3]
15. Intel INTC 112.5 [5]16. Cisco CSCO 100 [5.5]
17. Disney DIS 94.5 [2]
18. Home Depot HD 93 [1.5] 19. McDonald's MCD 92 [1]
20. Bank of America BAC 101.5 [10.5]
21. United Technologies UTX 71.5 [1]
22. American Express AXP 66 [1]
23. 3M MMM 65 [.5]
24. UnitedHealth UNH 60 [1]
25. Caterpillar CAT 56 [.5]
26. Boeing BA 52.5 [1]
27. DuPont DD 46.5 [1]
28. Hewlett-Packard HPQ 29.5 [2]
29. Travelers TRV 26.5 [.5]
30. Alcoa AA 9.5 [1]
****************************************
Here are the latest 8K, 10Q & 10K & Proxy & certain other SEC filings as of 10/4/12:
Symbol & Co. Name/Date of Filing/Form Filed/ Comments
AT&T T: 6/29/12 8K re: election of Scott F. Ford as Director
6/14/12 8K re: sale of approx. $2 bil of notes
6/7/12 8K re completion of sale of AT&T Advertising Solutions to Cerebrus
Alcoa AA: 10/3/12 8K re: EPA remedial plan for Grasse River
7/26/12 10Q for quarter ended 6/30/12
7/13/12 8K re: Transcript of 2Q earnings call
7/10/12 8K re: 2Q results
American Express AXP: 10/1/12 8K re: settlement re: U.S. card practices with regulators
9/17/12 8K re: delinq & write-off stats for June, July & Aug
8/15/12 8K re: dlinq. & write0off stats for months of May, June, and July
8/8/12 8K re: presentation from semi-annual Fin'l Community Meeting
8/2/12 10Q for quarter ended 6/30/12
7/20/12 8K re: election of David L. Vasella (Chairman of Bd. of Novartis) as Director
7/18/12 8K re: 2Q results
7/16/12 8K re: credt stats through 6/30/12
6/15/12 8K re: delinq. & write-off stats 3/31, 4/30 & 5/31/12
6/13/12 8K re: fin'l presentation of Vice-Chair Edward Gilligan
Bank of Am BAC: 9/28/12 8K re: settlement re: $1.6 bil regarding Merrill Lynch purchase
8/23/12 8K re: 4 new directors: Sharon Allen, Jack Bovender, Linda Hudson & David Yost
8/10/12 8K re: retirement of Vice Chiar Charles H. Noski as of 9/1
8/2/12 10Q for quarter ended 6/30/12
7/18/12 8K re: 2Q results
Boeing BA: 8/29/12 8K re: bylaw amendments
7/25/12 10Q and 8K re: 2nd quarter results ended 6/30/12
6/26/12 8K re: selection of Raymond L. Conner to replace Jim Albaugh as Pres/CEO of Boeing Comm'l Airplanes
5/3/12 8K re: amendment to bylaws reducing number of directors from 12 to 114/25/12 10Q for quarter ended 3/31
Caterpillar CAT: 9/28/12 8K re: price increases
9/21/12 8K re: Aug. dealer stats
9/17/12 8K re: credit agreement for $100 mil
9/7/12 S-4; 8/28/12 8K & 8/20/12 8K all re: exchange offer for debentures
8/17/12 8K re: 3 mos. dealer stats
8/10/12 8K re: debenture exchange
8/6/12 10Q re: quarter ended 6/30/12
7/27 8K re: debenture exchange
7/24/12 8K re: 3 mos. dealer states
6/26/12 8K re: safety problems at Wyoming mine
6/25/12 8K re: underwriting agreement re: issuance of $1.5 bil of debt
6/20/12 8K re: 3 month dealer stats thru 5/12
6/18/12 8K re: amended by-laws re: date of annual stockholders meeting
6/14/12 8K re: election of Jon M. Huntsman, Jr. to Bd. of Dirs.
6/13/12 8K re: increase of quarterly div to 52 cents payable 8/20 to 7/20 record holders
Chevron CVX: 10/3/12 8K re: election of Dr. Alice P. Gast to Board
8/2/12 10Q & 7/27/12 8K re: 2 Qtr. results ended 6/30/12
7/11/12 8K re: guidance for 2Q
6/4/12 8K re: voting results from annual stockholders meeting
5/27/12 proxy re: recommendation to vote against all stockholder proposals
5/3/12 10Q for quarter ended 3/31
5/3/12 Proxy material re: voting recommendations
Cisco CSCO : 10/4/12 8K re: appointment of Gary B. Moore as Pres & other exec appointments
9/26/12 14A Proxy re: Annual Shareholders Meeting on 11/15/12 at Santa Clara,CA
9/19/12 8K re: departure of Jerry Yang from Board
9/12/12 10K for year ended July 28 '12
8/15/12 8K re: 4Q and FY '12 earnings
8/2/12 8K re: appointment to Bd. of CEO of salesforce.com Marc Benioff and Kristina M. Johnson, CEO of enduring Hydro, LLC
6/27/12 8K re; execs' pre-arranged stock trading plan
6/13/12 8K re: director's pre-arranged stock trading plan
Coke KO: 9/14/12 8K re: exec changes
8/23/12 8K re: shareholder approval of stock split
7/1 8K re: new operating structure
7/27/12 8K re: Amendment to Articles of Incorp. to increase auth. shares & 2 for 1 stock split
'7/26/12 10Q for quarter ended 6/29/12
7/17/12 8K re; 2Q results
7/10/12 8K re: approval of shareholders for stock split
Disney DIS: 8/7/12 10Q & 8/7/12 8K results for 3rd quarter ended 6/30/12
6/11/12 8K re: $2.25 bil 5 year credit agreement
DuPont DD: 9/4/12 8K re: sale of Performance Coatings Div to Carlyle Group for $4.9 bil
7/24/12 8K and 7/24/12 10Q for quarter ended 6/30/12
5/1/12 8K re: Annual meeting of stockholders results
ExxonMobil XOM: 8/2/12 10Q & 7/26/12 8K re: 2Q results ended 6/30/12
6/1/12 8K re: voting results from annual shareholders meeting
5/16/12 proxy re: exec compensation
5/11/12 proxy re: voting recommendations
5/3/12 10Q ended 3/31
GE: 7/30/12 10Q re: quarter ended 6/30/12
7/30/12 8K re: election of John J. Brennan to Bd., he is Chairman Emeritus of Vanguard
7/23/12 8K re: resignation of John Krenicki as Vice Chair & exec officer at year end
7/20/12 8K re: 2Q results
6/12/12 8K re: election of Manjin Dekkers to Board of Dirs.
5/23/12 10Q/A amend 10Q for quarter ended 3/31/12
5/16/12 8K re: dividend of $475 mil from GECC to GE & increase of stock buyback program
Hewlett-Packard HPQ: 10/3/12 8K e: earnings outlook for '13 fiscal year
9/10/12 10Q & 8/22/12 8K re: quarter ended 7/31/12
8/8/12 8K re: write-down due to impairment of goodwill
6/8/12 10Q re: quarter ended 4/30/12
Home Depot HD: 9/21/12 8K re: election of mark Vadon to Board
8/22/12 10Q for qtr ended 7/29/12
8/14/12 8K re: quarter ended 7/29
8/7/12 8K re: purchase of U.S. Home systems and related Proxy statement
Intel INTC: 9/12/12 8K re: closed pruchase of ASWML Holding for $3.1 bil
9/7/12 8K re: lowering 3Q rev outlook
8/1/12 10Q for quarter ended 6/30/12
7/18/12 2 8Ks re: 2Q results
7/9/12 8K re; purchase of 10% of ASML for $2.1 bil
IBM: 9/25/12 8K re: election of Virginia M. Rometty as Chair of Board
8/1/12 8K re: closing of sale of IBM's Retail Store Solutions biz to Toshiba Tec
7/31/12 10Q for period ended 6/30/12
7/27/12 8K re: underwriting agreement for 1.875% notes due '22
7/19/12 & 7/18/12 8Ks re: 2Q results
JPMorganChase JPM: 9/24/12 8K re: offering of $3 bil of 3.25% Note due '22
9/19/12 8K re: clsoing of 2.9% Notes due '17
8/27/12 8K re: isswuance of 5.5% non-cumulative Pref shares, Series O
8/20/12 8K re: closing of $2.5 bil 2% Notes due '17
8/9/12 10Q for period ended 6/30/12
7/27/12 8K re: exec changes
7/13/12 8K re: 2Q results
7/13/12 8K re: restatement of 1Q results
6/13/12 8K re: CEO Jamie Dimon's testimony before US Senate Comm on Banking
6/12/12 8K re: redemption of $9 bil in Trust Preferred Capital Securities
Johnson & Johnson JNJ : 8/16/12 8K re: discontinuance of bapineuzumbab trials
8/2/12 10Q for quarter ended 7/1/12
7/20/12 8K re: settlement of shareholder deriv case in US Dist CT NJ
7/17/12 8K re: 2Q results
6/14/12 8K re: completion of Synthes purchase for $19.7 cash/stock
6/12/12 8K re: repurchase of shares from Goldman Sachs & JPMorgan
6/8/12 8K re: special charge of $600 mil related to legal charges related to Risperdal, Invega & Naterecor
5/8/12 8K re: sale of DePuy Orthopaedics to Biomet
McDonald's MCD: 9/28/12 8K re: adoption of accoutning standard
9/24/12 8K re: quarterly cash div
9/12/12 8K re: sales increase of 3.7% in Aug.
8/9/12 8K re: July '12 sales
8/6/12 10Q for quarter ended 6/30/12
7/23/12 8K re; 2Q results
7/20/12 8K re: various amendments to By-laws
6/18/12 8K re: stocks options to Donald Thompson CEO as of 7/1
6/11/12 8K re: May '12 sales
Merck MRK: 9/13/12 8K re: closing of sale of notes
8/7/12 10Q & 7/27/12 8K re: results of second quarter ended 6/30/12
5/25/12 8K re: voting results of 5/22 Annual meeting of shareholders
Microsoft MSFT: 9/18/12 8K re: increase in quarterly div & retirement of Raymond Gilmartin from Board
7/26/12 10K for year ended 6/30/12
7/19/12 8K re: 4Q & full year results
7/2/12 8K re: write-down to Online Services Div
6/18/12 8K re: Amendment to By-laws re: timing of Annual Meeting of Shareholders
5/3/12 8K re: election of Steve Luczo to Board, he is CEO of Seagate Tech
Pfizer PFE: 8/14/12 8K re: purchase of marketing rights to OTC Nexium from AstraZeneca
8/9/12 10Q & 7/31/12 8K re: results of 2 Qtr ended 7/1/12
5/23/12 8K re: exec promotions
5/10/12 10Q for quarter ended 4/1
5/1/12 8K re: 1 qtr results
Procter & Gamble PG: 9/21/12 14A proxy re: candidate for Board
9/6/12 8K re: FD disclosure re: Barcaly's Back to School consumer conf.
8/24/12 14A Proxy re: Annual Meeting of Shareholders on 10/9/12 in Cincinnati
8/16/12 Form 8-A & 8/16 & 8/14/12 8Ks re sales of notes
8/8/12 10K and 8/3/12 2 8Ks all re: fourth quarter results for year ended 6/30/12
7/18/12 8K re: Board proclaims support for CEO Bob McDonald
7/10/12 8K re: quarterly dividend of 0.562 cents per share
6/20/12 8K re: Deutsche Bank Conference Reg. FD disclosures
3M MMM: 10/3/12 8K re: $1.5 bil revolving credit agreement
10/1/12 8K re: contract to purchase Ceradyne Inc. for $35 per share
8/29/12 K re: $150 mil credit agreement
8/2/12 & 7/26/12 8K re: 2nd quarter results for quarter ended 6/30/12
7/26/12 8K re: sale of notes
6/26/12 8K re: issuance of $1.25 bil of notes
5/10/12 & 5/412 8Ks re: adoption of exec pre-arranged stock trading plans
Travelers TRV: 7/19/12 10Q & 7/19/12 8K re: results of quarter ender 6/30/12
5/25/12 8K re: voting results of 5/23 Annual Meeting of Shareholders.
UnitedHealth Group UNH: 9/10/12 re: FD disclosure re: Morgan Stanley Healthcare Conference
8/7/12 10Q re: quarter ended 6/30/12
United Technologies UTX: 9/12/12 8K re: election of Marshall Larsen to Board
7/31/12 8K re: purchase of Silver II for $3.46 bil
7/26/12 10Q & 7/26/12 8K re: results of 2nd qtr ended 6/30/12 & closing of Goodrich purchase and board and exec changer
6/18/12 8K re: issuance of equity unites
6/1/12 8K re: issuance of $9.8 bil of notes
Verizon Communications Inc. VZ: 7/30/12 10Q for quarter ended 6/30/12
7/19/12 Form S-3 re: registration of 29,750,000 shares
7/19/12 & 7/18/12 8Ks re: 2Q results
5/9/12 8K re: results of annual shareholders meeting
WalMart WMT: 9/6/12 10Q for quarter ended 7/31/12
8/16/12 8K re: 2 Qtr results
7/30/12 8K re: election to Board of Tim Flynn, former Chairman of KPMG
6/4/12 8K re: voting results of Annual Meeting of Shareholders
6/1/12 10Q for quarter ended 4/30/12
5/17/12 8K re: operating results & guidance
. END
No comments:
Post a Comment